Literature DB >> 27023325

International Society of Urological Pathology (ISUP) Grading of Prostate Cancer.

Lars Egevad1, Brett Delahunt, Andrew J Evans, David J Grignon, James G Kench, Glen Kristiansen, Katia R Leite, Hemamali Samaratunga, John R Srigley.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27023325     DOI： 10.1097/PAS.0000000000000642

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN： 0147-5185            Impact factor:   6.394


× No keyword cloud information.
  12 in total

Review 1.  One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason grading.

Authors:  John R Srigley; Brett Delahunt; Lars Egevad; Hemamali Samaratunga; John Yaxley; Andrew J Evans
Journal:  Can Urol Assoc J       Date:  2016 Sep-Oct       Impact factor: 1.862

2.  Prospective Evaluation of 18F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI.

Authors:  Sonia Gaur; Esther Mena; Stephanie A Harmon; Maria L Lindenberg; Stephen Adler; Anita T Ton; Joanna H Shih; Sherif Mehralivand; Maria J Merino; Bradford J Wood; Peter A Pinto; Ronnie C Mease; Martin G Pomper; Peter L Choyke; Baris Turkbey
Journal:  AJR Am J Roentgenol       Date:  2020-07-08       Impact factor: 3.959

3.  Combining clinical and MRI data to manage PI-RADS 3 lesions and reduce excessive biopsy.

Authors:  Shuo Yang; Wenlu Zhao; Shuangxiu Tan; Yueyue Zhang; Chaogang Wei; Tong Chen; Junkang Shen
Journal:  Transl Androl Urol       Date:  2020-06

4.  Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging.

Authors:  Dennie Meijer; Pim J van Leeuwen; Maarten L Donswijk; Thierry N Boellaard; Ivo G Schoots; Henk G van der Poel; Harry N Hendrikse; Daniela E Oprea-Lager; André N Vis
Journal:  BJU Int       Date:  2021-06-16       Impact factor: 5.969

5.  The current status of renal cell carcinoma and prostate carcinoma grading.

Authors:  Brett Delahunt; Lars Egevad; John Yaxley; Hemamali Samaratunga
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

6.  Developing Strategy to Predict the Results of Prostate Multiparametric Magnetic Resonance Imaging and Reduce Unnecessary Multiparametric Magnetic Resonance Imaging Scan.

Authors:  Junxiao Liu; Shuanbao Yu; Biao Dong; Guodong Hong; Jin Tao; Yafeng Fan; Zhaowei Zhu; Zhiyu Wang; Xuepei Zhang
Journal:  Front Oncol       Date:  2021-09-14       Impact factor: 6.244

7.  Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression.

Authors:  William Gesztes; Cara Schafer; Denise Young; Jesse Fox; Jiji Jiang; Yongmei Chen; Huai-Ching Kuo; Kuwong B Mwamukonda; Albert Dobi; Allen P Burke; Judd W Moul; David G McLeod; Inger L Rosner; Gyorgy Petrovics; Shyh-Han Tan; Jennifer Cullen; Shiv Srivastava; Isabell A Sesterhenn
Journal:  Sci Rep       Date:  2022-03-30       Impact factor: 4.996

8.  Optimizing MRI-targeted prostate biopsy: the diagnostic benefit of additional targeted biopsy cores.

Authors:  Chad R Tracy; Kevin J Flynn; Daniel D Sjoberg; Paul T Gellhaus; Catherine M Metz; Behfar Ehdaie
Journal:  Urol Oncol       Date:  2020-10-27       Impact factor: 2.954

9.  Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone.

Authors:  Junxiao Liu; Biao Dong; Wugong Qu; Jiange Wang; Yue Xu; Shuanbao Yu; Xuepei Zhang
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

10.  Prostate cancer grading, time to go back to the future.

Authors:  Lars Egevad; Brett Delahunt; David G Bostwick; Liang Cheng; Andrew J Evans; Troy Gianduzzo; Markus Graefen; Jonas Hugosson; James G Kench; Katia R M Leite; Jon Oxley; Guido Sauter; John R Srigley; Pär Stattin; Toyonori Tsuzuki; John Yaxley; Hemamali Samaratunga
Journal:  BJU Int       Date:  2020-11-27       Impact factor: 5.588
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.